Benzinga's Top Downgrades - Essent Group (NYSE:ESNT), Baidu (NASDAQ:BIDU)

Analysts at Brean Capital downgraded Nike Inc NKE from Buy to Hold. Nike shares dropped 2.57 percent to $53.92 in pre-market trading.
Analysts at UBS downgraded AT&T Inc. T from Buy to Neutral. AT&T shares fell 0.94 percent to $41.07 in pre-market trading.
Mizuho Securities downgraded Twitter Inc TWTR from Neutral to Underperform. Twitter shares fell 0.97 percent to $23.49 in pre-market trading.
Analysts at Longbow Research downgraded Tempur Sealy International Inc TPX from Buy to Neutral. Tempur Sealy shares fell 21.68 percent to $58.31 in pre-market trading.
Wedbush downgraded Alphabet Inc GOOGL from Neutral to Underperform. The price target for Alphabet has been lowered from $800 to $700. Alphabet shares fell 0.83 percent to $803.99 in pre-market trading.
Credit Suisse downgraded Macy's Inc M from Outperform to Neutral. Macy's shares fell 0.87 percent to $36.28 in pre-market trading.
Morgan Stanley downgraded Shopify Inc SHOP from Overweight to Equal-weight. The price target for Shopify has been raised from $37 to $47. Shopify shares gained 1.55 percent to close at $43.87 on Tuesday.
Analysts at Deutsche Bank downgraded Baidu Inc (ADR) BIDU from Buy to Hold. Baidu shares dropped 2.06 percent to $186.90 in pre-market trading.
Bank of America downgraded Essent Group Ltd ESNT from Buy to Neutral. Essent Group shares rose 0.30 percent to close at $26.68 on Tuesday.
Roth Capital downgraded Galectin Therapeutics Inc GALT from Buy to Sell. The price target for Galectin Therapeutics has been lowered from $3 to $0.75. Galectin Therapeutics shares fell 47.58 percent to $1.30 in pre-market trading.

Market News and Data brought to you by Benzinga APIs